YM155, a Novel Survivin Suppressant, Improves the Antitumor Effect of Rituximab and Rituximab-Containing Regimens in Diffuse Large B Cell Lymphoma (DLBCL) Xenograft Mouse Models

被引：0
|
作者：
Nakata, Mari [1 ]
Nakahara, Takahito [1 ]
Kita, Aya [1 ]
Mitsuoka, Keisuke [1 ]
Yamanaka, Kentaro [1 ]
Kaneko, Naoki [1 ]
Miyoshi, Sosuke [1 ]
Mori, Masamichi [1 ]
Koutoku, Hiroshi [1 ]
Sasamata, Masao [1 ]
机构：
[1] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki, Japan
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1064 / 1064
页数：1
相关论文
共 50 条
  • [41] Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B
    Wu, Chia-Yun
    Hsiao, Liang-Tsai
    Chiou, Tzeon-Jye
    Gau, Jyh-Pyng
    Liu, Jin-Hwang
    Yu, Yuan-Bin
    Wu, Yi-Tsui
    Liu, Chia-Jen
    Huang, Yu-Chung
    Hung, Man-Hsin
    Chen, Po-Min
    Huang, Yi-Hsiang
    Tzeng, Cheng-Hwai
    LEUKEMIA & LYMPHOMA, 2015, 56 (08) : 2357 - 2364
  • [42] Effect of rituximab (R) on clinical outcomes after autologous stem cell transplantation (ASCT) in pts with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
    Adegbola, O.
    Andreadis, C.
    Schuster, S. J.
    Chong, E. A.
    Nasta, S. D.
    Porter, D. L.
    Luger, S. M.
    Tsai, D. E.
    Cunningham, K.
    Stadtmauer, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy
    Maeshima, Akiko Miyagi
    Taniguchi, Hirokazu
    Fukuhara, Suguru
    Morikawa, Noriyuki
    Munakata, Wataru
    Maruyama, Dai
    Kim, Sung-Won
    Watanabe, Takashi
    Kobayashi, Yukio
    Tobinai, Kensei
    Tsuda, Hitoshi
    CANCER SCIENCE, 2012, 103 (10) : 1898 - 1904
  • [44] The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy
    Kawajiri, Akihisa
    Maruyama, Dai
    Maeshima, Akiko Miyagi
    Makita, Shin-ichi
    Kitahara, Hideaki
    Miyamoto, Ken-ichi
    Fukuhara, Suguru
    Suzuki, Tatsuya
    Munakata, Wataru
    Kobayashi, Yukio
    Tajima, Kinuko
    Itami, Jun
    Taniguchi, Hirokazu
    Tobinai, Kensei
    BLOOD, 2014, 124 (21)
  • [45] Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
    Liu, Zhiyu
    Xu-Monette, Zijun Y.
    Cao, Xin
    Visco, Carlo
    Tzankov, Alexander
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ai, Weiyun
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Farnen, John P.
    Moller, Michael B.
    Winter, Jane N.
    Piris, Miguel A.
    Medeiros, L. Jeffrey
    Young, Ken H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S216 - S216
  • [46] Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated with MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program
    Xu-Monette, Zijun Y.
    Dabaja, Bouthaina S.
    Tzankov, Alexander
    Visco, Carlo
    Miranda, Roberto N.
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, Wai Lap
    Van Krieken, Joannes H. J. M.
    Huh, Jooryung
    Ai, Weiyun Z.
    Ponzoni, Maurilio
    Ferreri, Andres
    Moller, Michael B.
    Zhao, Xiaoying
    Go, Ronald S.
    Winter, Jane N.
    Piris, Miguel Angel A.
    McDonnell, Timothy J.
    Li, Yong
    Medeiros, L. Jeffrey
    Young, Ken H.
    BLOOD, 2013, 122 (21)
  • [47] A PREDICTIVE SCORE FOR CNS DISSEMINATION AND ITS EFFECT ON CNS PROPHYLAXIS IN A MONO-INSTITUTIONAL SERIES OF 242 PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED IN THE RITUXIMAB ERA
    Ferreri, A. J.
    Calimeri, T.
    Cecchetti, C.
    Vignati, A.
    Foppoli, M.
    Scarfo, L.
    Sassone, M.
    Ponzoni, M.
    Caligaris-Cappio, F.
    HAEMATOLOGICA, 2016, 101 : 396 - 396
  • [48] Tumor and bone marrow uptakes on [18F]fluorodeoxyglucose positron emission tomography/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy
    Chang, Chin-Chuan
    Cho, Shih-Feng
    Tu, Hung-Pin
    Lin, Chia-Yang
    Chuang, Ya-Wen
    Chang, Shu-Min
    Hsu, Wen-Ling
    Huang, Ying-Fong
    MEDICINE, 2017, 96 (45)
  • [49] Prognostic significance of total metabolic tumor volume on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy
    Chang, Chin-Chuan
    Cho, Shih-Feng
    Chuang, Ya-Wen
    Lin, Chia-Yang
    Chang, Shu-Min
    Hsu, Wen-Ling
    Huang, Ying-Fong
    ONCOTARGET, 2017, 8 (59) : 99587 - 99600
  • [50] CD30-Expression Defines a Novel Subset of Diffuse Large B-Cell Lymphoma with Superior Clinical Outcome: A Report from the International DLBCL Rituximab-CHOP Consortium Program Study
    Hu, S.
    Tzankov, A.
    Visco, C.
    Orazi, A.
    Bhagat, G.
    Hsi, E. E.
    Ponzoni, M.
    Piris, M. A.
    Moller, M. B.
    Medeiros, L. J.
    Young, K. H.
    MODERN PATHOLOGY, 2013, 26 : 332A - 332A
12345